Ultragenyx Pharmaceutical RARE Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpensesOther.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's prepaid & other current?
- Ultragenyx Pharmaceutical (RARE) reported prepaid & other current of $9M in Q1 2026.
- How has Ultragenyx Pharmaceutical's prepaid & other current changed year-over-year?
- Ultragenyx Pharmaceutical's prepaid & other current decreased by 47.1% year-over-year, from $17M to $9M.
- What is the long-term trend for Ultragenyx Pharmaceutical's prepaid & other current?
- Over 2 years (2022 to 2024), Ultragenyx Pharmaceutical's prepaid & other current has grown at a 79.7% compound annual growth rate (CAGR), from -$3.8M to -$12.27M.
- What does prepaid & other current mean?
- This measures the change in cash outflows for expenses paid in advance of the services or goods being received. A decrease in this balance indicates that previously prepaid expenses are being recognized as costs, while an increase indicates higher cash outflows for future benefits. It is a key component in evaluating working capital efficiency and short-term liquidity management.